IL6 and neoplasm: Anti-IL-6 targeting is a promising therapeutic approach in many ways, since activation of IL-6 signaling is associated, for instance, with aggressive tumor growth [99], metastasizing [84,85] and poor responsiveness to chemo- and radiotherapy [86].